We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEC
4001
DELISTED
IEC Electronics Corp.
IEC
$2K ﹤0.01%
414
-27
-6% -$119
SHSP
4002
DELISTED
SharpSpring, Inc.
SHSP
$2K ﹤0.01%
390
-410
-51% -$1.68K
FLIR
4003
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$2K ﹤0.01%
+80
New +$2.5K
PRGX
4004
DELISTED
PRGX Global, Inc.
PRGX
$2K ﹤0.01%
+304
New +$1.5K
CEL
4005
DELISTED
Cellcom Israel, Ltd.
CEL
$2K ﹤0.01%
279
+179
+179% +$1.32K
OSB
4006
DELISTED
Norbord Inc.
OSB
$2K ﹤0.01%
102
-164
-62% -$3.39K
HDS
4007
DELISTED
HD Supply Holdings, Inc.
HDS
$2K ﹤0.01%
64
-597
-90% -$20.3K
PRCP
4008
DELISTED
Perceptron Inc
PRCP
$2K ﹤0.01%
388
-4,342
-92% -$20.3K
UCI
4009
DELISTED
E-TRACS UBS Bloomberg CMCI ETN
UCI
$2K ﹤0.01%
+141
New +$1.85K
TLI
4010
DELISTED
Western Asset Corporate Loan Fund Inc.
TLI
$2K ﹤0.01%
+205
New +$2.08K
WMGI
4011
DELISTED
Wright Medical Group Inc
WMGI
$2K ﹤0.01%
98
-690
-88% -$12.7K
AIMT
4012
DELISTED
Aimmune Therapeutics
AIMT
$2K ﹤0.01%
148
-2,712
-95% -$36.8K
PFNX
4013
DELISTED
Pfenex Inc.
PFNX
$2K ﹤0.01%
202
+83
+70% +$670
ZN
4014
DELISTED
Zion Oil & Gas, Inc.
ZN
$2K ﹤0.01%
1,525
-1,461
-49% -$2.4K
IOTS
4015
DELISTED
Adesto Technologies Corp
IOTS
$2K ﹤0.01%
619
+261
+73% +$1.08K
TUES
4016
DELISTED
Tuesday Morning Corp
TUES
$2K ﹤0.01%
300
-503
-63% -$3.68K
WEBK
4017
DELISTED
Wellesley Bancorp, Inc.
WEBK
$2K ﹤0.01%
116
+16
+16% +$319
TSLF
4018
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$2K ﹤0.01%
+100
New +$1.59K
SUMR
4019
DELISTED
Summer Infant, Inc.
SUMR
$2K ﹤0.01%
116
-24
-17% -$336
SITO
4020
DELISTED
SITO MOBILE, LTD
SITO
$2K ﹤0.01%
604
+300
+99% +$905
PIR
4021
DELISTED
Pier 1 Imports, Inc.
PIR
$2K ﹤0.01%
16
+11
+220% +$1.33K
IPHS
4022
DELISTED
Innophos Holdings, Inc.
IPHS
$2K ﹤0.01%
39
-2,163
-98% -$81.1K
FCSC
4023
DELISTED
Fibrocell Science Inc.
FCSC
$2K ﹤0.01%
+96
New +$2.99K
SSFN
4024
DELISTED
Stewardship Financial Corp
SSFN
$2K ﹤0.01%
314
-887
-74% -$5.4K
DEST
4025
DELISTED
Destination Maternity Corporation
DEST
$2K ﹤0.01%
323
-2,612
-89% -$17K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.